SCHEMBL6174261

SCHEMBL6174261

CSCC(=O)NCCC#Cc1ccc2ncnc(Nc3ccc(Oc4cccnc4)c(Cl)c3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.47
ERBB2 P04626 13/20 0.47
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
ERBB4 Q15303 1/20 0.45
LCK P06239 1/20 0.44
KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176489 0.92 ERBB2 (0.54) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6175531 0.87 ERBB2 (0.51) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6172180 0.86 ERBB2 (0.61) EGFRERBB2HDAC1HDAC6ERBB4
SCHEMBL6173784 0.86 ERBB2 (0.49) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6177169 0.85 ERBB2 (0.53) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6189113 0.85 ERBB2 (0.51) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6171826 0.84 ERBB2 (0.62) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6173857 0.84 ERBB2 (0.52) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6176765 0.84 ERBB2 (0.55) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL6174290 0.84 ERBB2 (0.53) EGFRERBB2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1292591-B1 SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PROD INC (US) 2005-02-02 EP disclosed